Literature DB >> 3976216

Hyperuricemia and gout.

B Lo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3976216      PMCID: PMC1305966     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  9 in total

Review 1.  Hyperuricemia and gout. Classification, complications and management.

Authors:  G R Boss; J E Seegmiller
Journal:  N Engl J Med       Date:  1979-06-28       Impact factor: 91.245

2.  Renal outcomes of gout and hyperuricemia.

Authors:  W J Fessel
Journal:  Am J Med       Date:  1979-07       Impact factor: 4.965

3.  Pseudopodagra. Differential diagnosis of gout.

Authors:  E C Huskisson; H W Balme
Journal:  Lancet       Date:  1972-08-05       Impact factor: 79.321

4.  Acute polyarticular gout.

Authors:  N M Hadler; W A Franck; N M Bress; D R Robinson
Journal:  Am J Med       Date:  1974-05       Impact factor: 4.965

5.  Acute adverse reactions attributed to allopurinol in hospitalised patients.

Authors:  G T McInnes; D H Lawson; H Jick
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

6.  Asymptomatic hyperuricemia: the case for conservative management.

Authors:  M H Liang; J F Fries
Journal:  Ann Intern Med       Date:  1978-05       Impact factor: 25.391

7.  The allopurinol hypersensitivity syndrome.

Authors:  G P Lupton; R B Odom
Journal:  J Am Acad Dermatol       Date:  1979-10       Impact factor: 11.527

8.  Management of gout.

Authors:  P A Simkin
Journal:  Ann Intern Med       Date:  1979-05       Impact factor: 25.391

9.  Preliminary criteria for the classification of the acute arthritis of primary gout.

Authors:  S L Wallace; H Robinson; A T Masi; J L Decker; D J McCarty; T F Yü
Journal:  Arthritis Rheum       Date:  1977-04
  9 in total
  1 in total

1.  Decrease in serum uric acid level following parathyroidectomy in patients with primary hyperparathyroidism.

Authors:  Q Y Duh; R C Morris; C D Arnaud; O H Clark
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.